UNSPSC 51434932: Fosinopril/hydrochlorothiazide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV400. This VA Drug Class (CV400) classifies this compound as belonging to the group ANTIHYPERTENSIVE COMBINATIONS.

UNSPSC 51434932 Fosinopril/hydrochlorothiazide, a Commodity code, tracks state and local procurement of this specific fixed-dose antihypertensive combination medication, though recent solicitations show broader purchasing patterns for emergency and general pharmaceutical supplies rather than this drug specifically. State and local governments buying under this code purchase medications through emergency medical services contracts, hospital pharmacy systems, and multi-state cooperative purchasing vehicles that bundle generic pharmaceuticals and over-the-counter products into consolidated supply agreements. Issuing bodies span city fire and rescue departments (such as Tampa Fire Rescue), state health and human services agencies (such as Texas HHS Commission), and multi-state cooperative purchasing alliances (such as the Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, which serves multiple state and local facilities across participating jurisdictions including Minnesota and Oregon). Scope typically includes bulk quantities of FDA-compliant, cGMP-certified medications with firm pricing structures, specific expiration-date requirements (often nine months to one year minimum shelf life), and compliance with the Drug Supply Chain Security Act and OSHA Hazard Communication Standards when hazardous materials are involved.

Recent activity concentrates in Texas, Florida, and the Upper Midwest, with Texas and Minnesota showing the most recent formal procurement activity. The City of Tampa's Purchasing Department issued an IFB (Bid No. 26-P-00188) in April 2026 for Advanced Life Support Medications valued at $40,000 to supply four specific emergency medication line items to Tampa Fire Rescue, with a one-year contract term and up to two additional one-year renewal options, requiring delivery within ten calendar days and bids submitted by April 8, 2026. The Texas Health and Human Services Commission posted an RFI in April 2026 to gather vendor capabilities on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and wholesaler channels, signaling the state's exploratory phase before formal procurement. The Minnesota Department of Administration's MMCAP issued an RFP due March 26, 2026, for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson), with awarded contracts effective July 1, 2026, and spanning two years with optional extensions. The Tampa solicitation includes a Small Local Business Enterprise sheltered-market designation with a 5 percent bid discount not to exceed $10,000.